A citation-based method for searching scientific literature

Helga Bergholtz, Tonje G Lien, David M Swanson, Arnoldo Frigessi, Maria Grazia Daidone, Jörg Tost, Fredrik Wärnberg, Therese Sørlie. NPJ Breast Cancer 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Aslaug Aamodt Muggerud, Michael Hallett, Hilde Johnsen, Kristine Kleivi, Wenjing Zhou, Simin Tahmasebpoor, Rose-Marie Amini, Johan Botling, Anne-Lise Børresen-Dale, Therese Sørlie,[...]. Mol Oncol 2010
78
100

Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
100

Intraductal carcinoma of the breast: follow-up after biopsy only.
D L Page, W D Dupont, L W Rogers, M Landenberger. Cancer 1982
474
100

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
298
100

pROC: an open-source package for R and S+ to analyze and compare ROC curves.
Xavier Robin, Natacha Turck, Alexandre Hainard, Natalia Tiberti, Frédérique Lisacek, Jean-Charles Sanchez, Markus Müller. BMC Bioinformatics 2011
100

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.
Mark D Robinson, Davis J McCarthy, Gordon K Smyth. Bioinformatics 2010
100

Addressing overdiagnosis and overtreatment in cancer: a prescription for change.
Laura J Esserman, Ian M Thompson, Brian Reid, Peter Nelson, David F Ransohoff, H Gilbert Welch, Shelley Hwang, Donald A Berry, Kenneth W Kinzler, William C Black,[...]. Lancet Oncol 2014
276
100


A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.
Martin C Abba, Ting Gong, Yue Lu, Jaeho Lee, Yi Zhong, Ezequiel Lacunza, Matias Butti, Yoko Takata, Sally Gaddis, Jianjun Shen,[...]. Cancer Res 2015
67
100

Predicting and affecting response to cancer therapy based on pathway-level biomarkers.
Rotem Ben-Hamo, Adi Jacob Berger, Nancy Gavert, Mendy Miller, Guy Pines, Roni Oren, Eli Pikarsky, Cyril H Benes, Tzahi Neuman, Yaara Zwang,[...]. Nat Commun 2020
6
100

Long Noncoding RNA and Cancer: A New Paradigm.
Arunoday Bhan, Milad Soleimani, Subhrangsu S Mandal. Cancer Res 2017
931
100


Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Emma J Groen, Lotte E Elshof, Lindy L Visser, Emiel J Th Rutgers, Hillegonda A O Winter-Warnars, Esther H Lips, Jelle Wesseling. Breast 2017
73
100

Long Non-Coding RNA in the Pathogenesis of Cancers.
Yujing Chi, Di Wang, Junpei Wang, Weidong Yu, Jichun Yang. Cells 2019
172
100

Progression from ductal carcinoma in situ to invasive breast cancer: revisited.
Catherine F Cowell, Britta Weigelt, Rita A Sakr, Charlotte K Y Ng, James Hicks, Tari A King, Jorge S Reis-Filho. Mol Oncol 2013
121
100


Selection bias in gene extraction on the basis of microarray gene-expression data.
Christophe Ambroise, Geoffrey J McLachlan. Proc Natl Acad Sci U S A 2002
589
100


Regularization Paths for Generalized Linear Models via Coordinate Descent.
Jerome Friedman, Trevor Hastie, Rob Tibshirani. J Stat Softw 2010
100

Ductal carcinoma in situ: to treat or not to treat, that is the question.
Maartje van Seijen, Esther H Lips, Alastair M Thompson, Serena Nik-Zainal, Andrew Futreal, E Shelley Hwang, Ellen Verschuur, Joanna Lane, Jos Jonkers, Daniel W Rea,[...]. Br J Cancer 2019
41
100

Molecular basis of invasion in breast cancer.
E A McSherry, S Donatello, A M Hopkins, S McDonnell. Cell Mol Life Sci 2007
60
100

MFAP2 promotes epithelial-mesenchymal transition in gastric cancer cells by activating TGF-β/SMAD2/3 signaling pathway.
Jian-Kai Wang, Wen-Juan Wang, Hong-Yi Cai, Bin-Bin Du, Ping Mai, Li-Juan Zhang, Wen Ma, Yong-Guo Hu, Shi-Fang Feng, Guo-Ying Miao. Onco Targets Ther 2018
21
100

Pathway-Based Drug Response Prediction Using Similarity Identification in Gene Expression.
Seyed Ali Madani Tonekaboni, Gangesh Beri, Benjamin Haibe-Kains. Front Genet 2020
2
100

Distribution of myofibroblast cells and microvessels around invasive ductal carcinoma of the breast and comparing with the adjacent range of their normal-to-DCIS zones.
Shahriar Dabiri, Amin Talebi, Jahanbanoo Shahryari, Manzoumeh Shamsi Meymandi, Hossein Safizadeh. Arch Iran Med 2013
7
100


Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
Mingdi Zhang, Hongliang Chen, Maoli Wang, Fang Bai, Kejin Wu. Biosci Rep 2020
6
100

The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.
Michael S Toss, Asima Abidi, Dorothea Lesche, Chitra Joseph, Sakshi Mahale, Hugo Saunders, Tanjina Kader, Islam M Miligy, Andrew R Green, Kylie L Gorringe,[...]. Br J Cancer 2020
6
100

DNA methylation at enhancers identifies distinct breast cancer lineages.
Thomas Fleischer, Xavier Tekpli, Anthony Mathelier, Shixiong Wang, Daniel Nebdal, Hari P Dhakal, Kristine Kleivi Sahlberg, Ellen Schlichting, Anne-Lise Børresen-Dale, Elin Borgen,[...]. Nat Commun 2017
55
100

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.
Jia-Min B Pang, Peter Savas, Andrew P Fellowes, Gisela Mir Arnau, Tanjina Kader, Ravikiran Vedururu, Chelsee Hewitt, Elena A Takano, David J Byrne, David Yh Choong,[...]. Mod Pathol 2017
28
100

PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion.
G Wang, Q Zhang, Y Song, X Wang, Q Guo, J Zhang, J Li, Y Han, Z Miao, F Li. Cell Death Dis 2015
26
100

Classification of ductal carcinoma in situ by gene expression profiling.
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
117
100

Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer.
Robert Lesurf, Miriam Ragle Aure, Hanne Håberg Mørk, Valeria Vitelli, Steinar Lundgren, Anne-Lise Børresen-Dale, Vessela Kristensen, Fredrik Wärnberg, Michael Hallett, Therese Sørlie. Cell Rep 2016
42
100

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.
Kylie L Gorringe, Stephen B Fox. Front Oncol 2017
46
100

Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo.
Dimitris Anastassiou, Viktoria Rumjantseva, Weiyi Cheng, Jianzhong Huang, Peter D Canoll, Darrell J Yamashiro, Jessica J Kandel. BMC Cancer 2011
79
100

Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery,[...]. Clin Cancer Res 2008
110
100


Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
Ruyue Zhang, Qingwen Zhu, Detao Yin, Zhe Yang, Jinxiu Guo, Jingmin Zhang, Yubing Zhou, Jane J Yu. Front Oncol 2021
2
100

Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Xu Zhang, Shuai Huang, Junchao Guo, Li Zhou, Lei You, Taiping Zhang, Yupei Zhao. Int J Oncol 2016
44
100

Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells.
Giulia Daniele, Giorgia Simonetti, Caterina Fusilli, Ilaria Iacobucci, Angelo Lonoce, Antonio Palazzo, Mariana Lomiento, Fabiana Mammoli, Renè Massimiliano Marsano, Elena Marasco,[...]. Haematologica 2017
5
100

Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target.
Jing Liu, Jia-Xin Shen, Hua-Tao Wu, Xiao-Li Li, Xiao-Fen Wen, Cai-Wen Du, Guo-Jun Zhang. Discov Med 2018
57
100

Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions.
E R Motrescu, S Blaise, N Etique, N Messaddeq, M-P Chenard, I Stoll, C Tomasetto, M-C Rio. Oncogene 2008
75
100

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
353
100

The diagnostic challenge of low-grade ductal carcinoma in situ.
Tracy Onega, Donald L Weaver, Paul D Frederick, Kimberly H Allison, Anna N A Tosteson, Patricia A Carney, Berta M Geller, Gary M Longton, Heidi D Nelson, Natalia V Oster,[...]. Eur J Cancer 2017
21
100

Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display.
Weijun Pan, Marc Arnone, Marvin Kendall, Robert H Grafstrom, Steven P Seitz, Zelda R Wasserman, Charles F Albright. J Biol Chem 2003
45
100

The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.
M G Wallis, K Clements, O Kearins, G Ball, J Macartney, G M Lawrence. Br J Cancer 2012
43
100

Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
94
100

MAM domain containing 2 is a potential breast cancer biomarker that exhibits tumour-suppressive activity.
Hyeonhee Lee, Bum-Chan Park, Jong Soon Kang, Yeongmi Cheon, Soojin Lee, Pil Jae Maeng. Cell Prolif 2020
2
100

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
163
100

Bias in error estimation when using cross-validation for model selection.
Sudhir Varma, Richard Simon. BMC Bioinformatics 2006
439
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.